Furthermore, osteosarcoma cells frequently exploit immune checkpoint pathways to evade immune surveillance, making PD-1/PD-L1 blockade an essential strategy to enhance anti-tumor T cell responses (Lussier et al., 2015a; Lussier et al., 2015b; Chen et al., 2020). The gene discussed is CD274; the disease is neoplasm.